McKesson Other Operating Income or Expenses 2010-2024 | MCK

McKesson annual/quarterly other operating income or expenses history and growth rate from 2010 to 2024. Other operating income or expenses can be defined as the aggregate amount of all operating expenses either too small to report separately or that cannot be standardized into another Zacks field.
  • McKesson other operating income or expenses for the quarter ending September 30, 2024 were $0.004B, a 100% increase year-over-year.
  • McKesson other operating income or expenses for the twelve months ending September 30, 2024 were $-0.257B, a 4383.33% decline year-over-year.
  • McKesson annual other operating income or expenses for 2024 were $-0.147B, a 1937.5% decline from 2023.
  • McKesson annual other operating income or expenses for 2023 were $0.008B, a 102.92% decline from 2022.
  • McKesson annual other operating income or expenses for 2022 were $-0.274B, a 96.55% decline from 2021.
McKesson Annual Other Operating Income or Expenses
(Millions of US $)
2024 $-147
2023 $8
2022 $-274
2021 $-7,936
2020 $-82
2019 $-37
2018 $37
2017 $3,947
2016 $
2015 $-150
2014 $-68
2013 $-72
2012 $-149
2011 $-213
2010 $20
2009 $-493
McKesson Quarterly Other Operating Income or Expenses
(Millions of US $)
2024-09-30 $4
2024-06-30 $-112
2024-03-31 $-149
2023-12-31 $0
2023-09-30 $2
2023-06-30 $0
2023-03-31 $3
2022-12-31 $1
2022-09-30 $9
2022-06-30 $-5
2022-03-31 $-81
2021-12-31 $-7
2021-09-30 $-112
2021-06-30 $-74
2021-03-31
2020-12-31 $-8,067
2020-09-30 $0
2020-06-30 $131
2020-03-31 $6,779
2019-12-31 $-2,535
2019-09-30 $-2,196
2019-06-30 $-2,130
2019-03-31 $6,182
2018-12-31 $-2,156
2018-09-30 $-2,033
2018-06-30 $-2,030
2018-03-31 $5,957
2017-12-31 $-1,984
2017-09-30 $-2,009
2017-06-30 $-1,927
2017-03-31 $9,749
2016-12-31 $-1,981
2016-09-30 $-1,886
2016-06-30 $-1,935
2016-03-31
2015-12-31 $-1,952
2015-09-30 $-1,890
2015-06-30 $-1,917
2015-03-31 $6,076
2014-12-31 $-2,098
2014-09-30 $-2,077
2014-06-30 $-2,051
2014-03-31 $3,899
2013-12-31 $-1,357
2013-09-30 $-1,335
2013-06-30 $-1,275
2013-03-31 $3,218
2012-12-31 $-1,147
2012-09-30 $-1,077
2012-06-30 $-1,066
2012-03-31 $3,131
2011-12-31 $-1,074
2011-09-30 $-1,169
2011-06-30 $-1,037
2011-03-31 $2,808
2010-12-31 $-1,154
2010-09-30 $-949
2010-06-30 $-918
2010-03-31 $2,678
2009-12-31 $-946
2009-09-30 $-868
2009-06-30 $-844
2009-03-31 $2,722
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $78.151B $308.951B
McKesson Corporation is a health care services and information technology company. McKesson operates through two segments: The Distribution Solutions segment distributes branded and generic pharmaceutical drugs along with other healthcare-related products on a global basis worldwide. The segment also provides practice management, technology, clinical support and business solutions to community-based oncology and other specialty practices. In addition, the segment provides specialty pharmaceutical solutions for pharmaceutical manufacturers including offering multiple distribution channels and study access to oncology physicians. The Technology Solutions segment provides enterprise-wide clinical, patient care, financial, supply chain, and strategic management software solutions. per segment realignment, McKesson reported revenues through four segments: U.S. Pharmaceutical and Specialty Solutions, Internation, Medical-Surgical Solutions and Prescription Technology Solutions.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $64.352B 16.92
Cardinal Health (CAH) United States $28.637B 15.53
West Pharmaceutical Services (WST) United States $22.024B 44.99
Labcorp (LH) United States $19.758B 16.38
Cooper (COO) United States $19.726B 28.08
Align Technology (ALGN) United States $16.616B 31.80
Henry Schein (HSIC) United States $9.331B 17.78
Merit Medical Systems (MMSI) United States $6.102B 31.16
DENTSPLY SIRONA (XRAY) United States $3.753B 10.20
CONMED (CNMD) United States $2.216B 18.49
Patterson (PDCO) United States $1.799B 9.49
STAAR Surgical (STAA) United States $1.288B 47.53
Lifevantage (LFVN) United States $0.170B 22.60
Pro-Dex (PDEX) United States $0.147B 29.36